Keyphrases
2 Receptor
25%
A1 Receptor
50%
Active Avoidance
25%
Alzheimer's Disease
25%
Brain Stroke
25%
Brain-derived Neurotrophic Factor
25%
C57BL
25%
Cholinergic Signaling
25%
Cognition Enhancement
25%
Cognitive Deficits
100%
Cognitive Enhancer
25%
D2-D3
25%
D2-like
25%
D4 Dopamine Receptor
25%
Drug Discovery
25%
Enhancement Drugs
25%
High Affinity
25%
Learning Impairment
25%
Low Affinity
25%
Memory Loss
25%
Muscarinic Antagonists
100%
Muscarinic Receptors
50%
Novel Therapeutics
25%
Parkinson's Disease
25%
Phenotypic Screening
25%
Rat Astrocytes
25%
Receptor Agonist
25%
Scopolamine
50%
Scopolamine-induced Memory Impairment
25%
Selective Agonist
25%
Selective Ligands
100%
Sigma-1 Receptor
100%
Symptom Relief
25%
Task Avoidance
25%
Therapeutic Agents
25%
Traumatic Brain Injury
25%
Water Maze Test
25%
Neuroscience
Active Avoidance
25%
Agonist
25%
Alzheimer's Disease
25%
Astrocyte
25%
Brain-Derived Neurotrophic Factor
25%
Cholinergic
25%
Cognitive Disorders
100%
Dopamine Receptor
25%
Eicosanoid Receptor
25%
Enhancer Region
25%
Learning Disabilities
25%
Muscarinic Acetylcholine Receptor
50%
Muscarinic Antagonist
100%
Neurotrauma
25%
Parkinson's Disease
25%
Receptor Agonists
25%
Scopolamine
50%
Scopolamine-Induced Cognitive Defect
25%
Sigma 1 Opiate Receptor
100%
Traumatic Brain Injury
25%
Water Maze
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
25%
Brain Derived Neurotrophic Factor
25%
C57BL 6 Mouse
25%
Cholinergic Receptor Stimulating Agent
25%
Cognitive Defect
100%
Dopamine Receptor
25%
Drug Discovery
25%
Learning Disorder
25%
Mouse
100%
Muscarinic Receptor
50%
Muscarinic Receptor Blocking Agent
100%
Parkinson's Disease
25%
Receptor
25%
Receptor Agonist
25%
Scopolamine
50%
Scopolamine-Induced Cognitive Defect
25%
Sigma 1 Opiate Receptor
100%
Traumatic Brain Injury
25%